A Trial to Determine the Optimal Bupivacaine Dose for Initiation of Labor Epidural Pain Relief
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 100
- 试验地点
- 1
- 主要终点
- Verbal Numerical Rating Score (0-10, with higher scores meaning more pain); goal with analgesia is < 3/10
研究概览
简要总结
To estimate the dose of bupivacaine required to achieve initial effective comfort in 90% of patients (ED90) via the epidural (DPE or EPL) technique in women undergoing labor.
详细描述
The primary objective of our study is to use a biased coin up-down allocation methodology to estimate the dose of bupivacaine required to achieve initial effective comfort in 90% of patients (ED90) via the epidural (DPE or EPL) technique in women undergoing labor induction or augmentation; we hypothesize that we will be able to determine the ED90 of bupivacaine for each technique with adequate precision to inform the optimal doses.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Triple (Participant, Investigator, Outcomes Assessor)
盲法说明
The biased-coin allocation after each successful response will be implemented by flipping a virtual biased coin (10% vs. 90% probability of randomizing the next patient to the lower vs. same dose than received by the last patient with the same epidural technique) using R statistical software (R Foundation for Statistical Computing, Vienna, Austria). Care Provider (Clinical Anesthesiologist) will administer the identified dose, then summon blinded observer.
入排标准
- 年龄范围
- 18 Years 至 50 Years（Adult）
- 性别
- Female
- 接受健康志愿者
- 是
入选标准
- •Parturient with no major co-morbidities
- •Singleton, vertex gestation at term (37-42 weeks)
- •Less than or equal to 5 cm dilation
- •Desire to receive epidural labor analgesia
- •Numerical Rating Scale greater or equal to 5 (NRS 0-10, where 0 = no pain, and 10 = worst pain imaginable), at time of epidural labor analgesia request.
排除标准
- •Current or historical evidence of clinically significant disease or condition, including diseases of pregnancy (i.e preeclampsia, gestational diabetes)
- •Any contraindication to the administration of an epidural technique
- •History of hypersensitivity or idiosyncratic reaction to an amide local anesthetic agent
- •Current or historical evidence of a disease which may result in the risk of a cesarean delivery (i.e. history of uterine rupture). NB: Exception-trial of labor after cesarean delivery (TOLAC) will be eligible.
- •Evidence of anticipated fetal anomalies
研究组 & 干预措施
Dural Puncture Epidural Technique
Laboring women receiving the Dural Puncture Epidural (DPE) Technique with dose of Bupivacaine 0.25% diluted to 20 mL with isotonic sterile 0.9% saline. The first subject in the DPE group will receive an initial dose of bupivacaine 25 mg, with an endpoint being the achievement of an NRS < 3 at 30 min. Subsequent patients are administered bupivacaine doses determined by the response of the previous subject, as per the biased coin method. The subsequent up and down interval doses are bupivacaine 2.5 mg (1 mL) increments, with an anticipated dose range from 20 mg to 40 mg.
干预措施: Bupivacaine Hydrochloride (Drug)
Epidural Technique
Laboring women receiving the Conventional Epidural Technique (EPL) with dose of Bupivacaine 0.25% diluted to 20 mL with isotonic sterile 0.9% saline. The first subject in the EPL group will receive an initial dose of bupivacaine 25 mg, with an endpoint being the achievement of an NRS < 3 at 30 min. Subsequent patients are administered bupivacaine doses determined by the response of the previous subject, as per the biased coin method. The subsequent up and down interval doses are bupivacaine 2.5 mg (1 mL) increments, with an anticipated dose range from 20 mg to 40 mg.
干预措施: Bupivacaine Hydrochloride (Drug)
结局指标
主要结局
Verbal Numerical Rating Score (0-10, with higher scores meaning more pain); goal with analgesia is < 3/10
时间窗: 30 minutes
Pain Score (0=no pain, 10= worst pain imaginable)
ED90
时间窗: 30 minutes
The dose of bupivacaine with which 90% of participants achieve adequate analgesia (NRS\<3 at 30min)
次要结局
未报告次要终点
研究者
Lawrence Ching Tsen
Associate Professor of Anesthesia
Brigham and Women's Hospital